Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: Implications for NeuroAIDS pathogenesis

American Journal of Pathology

Volumn 176, Issue 6, 2010, Pages 2819-2830

  King, Jessie E ^a   Eugenin, Eliseo A ^a   Hazleton, Joy E ^a   Morgello, Susan ^b   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR SUBUNIT 2 A; TRANSACTIVATOR PROTEIN; TYROSINE; UNCLASSIFIED DRUG; MAP2 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; NR2A NMDA RECEPTOR; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENCEPHALITIS; ENZYME ACTIVITY; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL LESION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TISSUE SECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN SUBUNIT; VIROLOGY;

ANIMALS; BRAIN; CELLS, CULTURED; HIV; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; PHOSPHORYLATION; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; SRC-FAMILY KINASES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TYROSINE;

EID: 77953184066     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090642     Document Type: Article

References (62)

1. McArthur JC: HIV dementia: an evolving disease. J Neuroimmunol 2004, 157:3-10
2. Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002, 8:115-121
3. King JE, Eugenin EA, Buckner CM, Berman JW: HIV tat and neurotoxicity. Microb Infect 2006, 8:1347-1357
4. Bell JE: The neuropathology of adult HIV infection. Rev Neurol (Paris) 1998, 154:816-829
5. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD: Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996, 39:705-711
6. Torres-Munoz JE, Nunez M, Petito CK: Successful application of hyperbranched multidisplacement genomic amplification to detect HIV-1 sequences in single neurons removed from autopsy brain sections by laser capture microdissection. J Mol Diagn 2008, 10:317-324
7. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A: Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995, 37:373-380
8. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003, 85:1299-1311
9. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MVL, Berman JW: HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci USA 2007, 104:3438-3443
10. Haughey NJ, Holden CP, Nath A, Geiger JD: Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat. J Neurochem 1999, 73:1363-1374
11. Yao H, Peng F, Dhillon N, Callen S, Bokhari S, Stehno-Bittel L, Ahmad SO, Wang JQ, Buch S: Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J Neurosci 2009, 29:1657-1669
12. Kohr G, Seeburg PH: Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J Physiol 1996, 492:445-452 (Pubitemid 26137754)
13. Wang YT, Salter MW: Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 1994, 369:233-235
14. Wang YT, Yu XM, Salter MW: Ca(2+)-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc Natl Acad Sci USA 1996, 93:1721-1725
15. Chung HJ, Huang YH, Lau L-F, Huganir RL: Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B Subunit PDZ Ligand. J Neurosci 2004, 24:10248-10259
16. Scott DB, Blanpied TA, Ehlers MD: Coordinated PKA and PKC phosphorylation suppresses RXR-mediated ER retention and regulates the surface delivery of NMDA receptors. Neuropharmacology 2003, 45:755-767
17. Scott DB, Blanpied TA, Swanson GT, Zhang C, Ehlers MD: An NMDA Receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci 2001, 21:3063-3072 (Pubitemid 32323488)
18. Nishizawa Y: Glutamate release and neuronal damage in ischemia. Life Sci 2001, 69:369-381
19. Yu X-M, Askalan R, Keil GJ II, Salter MW: NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 1997, 275:674-678
20. Hou X-Y, Zhang G-Y, Yan J-Z, Chen M, Liu Y: Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia. Brain Res 2002, 955:123-132
21. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T: PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci USA 1999, 96:435-440
22. Huang Y-Q, Lu W-Y, Ali DW, Pelkey KA, Pitcher GM, Lu YM, Aoto H, Roder JC, Sasaki T, Salter MW, MacDonald JF: CAKβ/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 2001, 29:485-496
23. Ma J, Zhang G, Liu Y, Yan J, ZB H: Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Lyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia. Neurosci Res 2004, 49:357-362
24. Zalewska T, Ziemka-Nalecz M, Domanska-Janik K: Transient forebrain ischemia effects interaction of src, fak and pyk2 with the NR2B subunit of N-methyl-D-aspartate receptor in gerbil hippocampus. Brain Res 2005, 1042:214-223
25. Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM: Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol 2009, 215:253-263
26. Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G: HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 2001, 288:301-308
27. Cheng J, Nath A, Knudsen B, Hochman S, Geiger JD, Ma M, Magnuson DS: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 1998, 82:97-106
28. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO: Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998, 95:3117-3121
29. D'Aversa TG, Yu KO, Berman JW: Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 2004, 10:86-97
30. Johnston JB, Zhang K, Silva C, Shalinsky DR, Conant K, Ni W, Corbett D, Yong VW, Power C: HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 2001, 49:230-241
31. Kruman II, Nath A, Mattson MP: HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998, 154:276-288
32. Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A: NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 2008, 28:12190-12198
33. Nath A, Conant K, Chen P, Scott C, Major EO: Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: a hit and run phenomenon. J Biol Chem 1999, 274:17098-17102 (Pubitemid 129519040)
34. Perez A, Probert AW, Wang KK, Sharmeen L: Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 2001, 7:1-10 (Pubitemid 32904353)
35. Woodman SE, Benveniste EN, Nath A, Berman JW: Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J Neurovirol 1999, 5:678-684 (Pubitemid 30032093)
36. Blom N, Gammeltoft S, Brunak S: Sequence- and structure-based prediction of eukaryotic protein phosphorylation sits. J Mol Biol 1999, 294:1352-1362
37. Bi R, Rong Y, Bernard A, Khrestchatisky M, Baudry M: Src-mediated tyrosine phosphorylation of NR2 subunits of N-methyl-D-aspartate receptors protects from calpain-mediated truncation of their C-terminal domains. J Biol Chem 2000, 275:26477-26483
38. French D, Kelly T, Buhl S, Scharff MD: Somatic cell genetic analysis of myelomas and hybridomas. Methods Enzymol 1987, 151:50-66
39. Liu Y, Zhang G, Gao C, Hou X: NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion. Brain Res 2001, 909:51-58
40. Chen M, Hou X, Zhang G: Tyrosine kinase and tyrosine phosphatase participate in regulation of interactions of NMDA receptor subunit 2A with Src and Fyn mediated by PSD-95 after transient brain ischemia. Neurosci Lett 2003, 339:29-32
41. Liu Y, Hou X-Y, Zhang G-Y, Xu T-L: L-type voltage-gated calcium channel attends regulation of tyrosine phosphorylation of NMDA receptor subunit 2A induced by transient brain ischemia. Brain Res 2003, 972:142-148
42. Cheung HH, Takagi N, Teves L, Logan R, Wallace MC, Gurd JW: Altered association of protein tyrosine kinases with postsynaptic densities after transient cerebral ischemia in the rat brain. J Cereb Blood Flow Metab 2000, 20:505-512 (Pubitemid 30164895)
43. Tian G, Cory M, Smith AA, Knight WB: Structural determinants for potent selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines. Biochemistry 2001, 40:7084-7091 (Pubitemid 32554030)
44. Yang M, Leonard JP: Identification of mouse NMDA receptor subunit NR2A C-terminal tyrosine sites phosphorylated by coexpression with v-Src. J Neurochem 2001, 77:580-588
45. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherne M, Gelman B, Morgello S, Singer E, Grant I, Masliah E: Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 2009, 1-11
46. Chen B-S, Roche KW: Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368
47. Shamloo M, Wieloch T: Changes in protein tyrosine phosphorylation in the rat brain after cerebral ischemia in a model of ischemic tolerance. J Cereb Blood Flow Metab 1999, 19:173-183 (Pubitemid 29284266)
48. Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG: Alterations in subunit expression. composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 2000, 57:342-352 (Pubitemid 30084511)
49. Sze C-I, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ: N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci 2001, 182:151-159
50. Grosshans DR, Clayton DA, Coultrap SJ, Browning MD: LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nature Neurosci 2002, 5:27-33
51. Zheng F, Gingrich MB, Traynelis SF, Conn PJ: Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Nature Neurosci 1998, 1:185-191 (Pubitemid 128652761)
52. Iwamoto T, Yamada Y, Hori K, Watanabe Y, Sobue K, Inui M: Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins. J Neurochem 2004, 89:100-108 (Pubitemid 38420678)
53. Kalia LV, Gingrich JR, Salter MW: Src in synaptic transmission and plasticity. Oncogene 2004, 23:8007-8016
54. Yamada Y, Iwamoto T, Watanabe Y, Sobue K, Inui M: PSD-95 eliminates Src-induced potentiation of NR1/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition. J Neurochem 2002, 81:758-764
55. Seabold GK, Burette A, Lim IA, Weinberg RJ, Hell JW: Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the Src homology 3 domains of PSD-95 and SAP102. J Biol Chem 2003, 278:15040-15048
56. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001, 78:457-467
57. Cull-Candy SG, Leszkiewicz DN: Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004, 2004:re16, 1-9
58. Cull-Candy S, Brickley S, Farrant M: NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001, 11:327-335
59. Eugenin EA, King JE, Hazleton JE, Major EO, Bennett MV, Zukin RS, Berman JW: Differences in NMDA receptor expression during human development determine the response of neurons to HIV-Tat-mediated neurotoxicity. Neurotox Res 2010, DOI: 10.100715/2640-010-9150-X
60. Kalia LV, Kalia SK, Salter MW: NMDA receptors in clinical neurology: excitatory times ahead. Lancet 2008, 7:742-755
61. Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer, EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA; Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium: Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 2007, 21:1877-1886
62. Schifitto G, Yiannoutsos CT, Simpson DM, Marra CM, Singer EJ, Kolson DL, Nath A, Berger JR, Navia B, Team AACTG: A placebocontrolled study of memantine for the treatment of human immunodeficiency viruses associated sensory neuropathy. J Neurovirol 2006, 12:328-331